Please login to the form below

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

AZ builds case for its COPD triple as it chases GSK’s Trelegy

Breztri – which combines long-acting beta agonist (LABA) formoterol fumarate, long-acting muscarinic antagonist (LAMA) glycopyrronium and inhaled corticosteroid (ICS) budesonide – is playing catch-up in the market with GlaxoSmithKline’s

Latest news

Sanofi's Dupixent gains asthma approval in Europe

inflammation. However, Dupixent can only be used in this setting when patients have used at least one other maintenance treatment, along with high dose inhaled corticosteroid (ICS).
AZ prepares to file COPD triple, taking on rival GSK

The KRONOS trial of PT010 – which combines long-acting beta agonist (LABA) formoterol fumarate, long-acting muscarinic antagonist (LAMA) glycopyrronium and inhaled corticosteroid (ICS) budesonide – was presented at a medical congress ... triple –
AZ rival to GSK’s COPD drug Anoro fails head-to-head test

The real battleground between the two companies is expected to be three-drug combinations for COPD, with an inhaled corticosteroid (ICS) added to the LAMA/LABA duo.
AZ’s COPD triple data sets up market clash with GSK

on LABA vilanterol, LAMA umeclidinium and ICS fluticasone furoate - in the US and Europe last year.
EMA approves GSK’s triple COPD therapy

moderate to severe COPD who are not adequately treated by the combination of an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). ... The same indication was approved by the FDA in September, and makes Trelegy the first drug on the

More from news
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest Intelligence

NHS regional footprints

CCGs in action. In Nottinghamshire, six CCGs have joined forces to lead the strategic development of integrated care within the geographical area originally allocated to the Nottinghamshire ICS.
Deal Watch table for August 2014

600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Early diagnosis underpins NHS cancer strategy

The Cancer Alliances will advise Sustainability and Transformation Partnership (STP) and Integrated Care System (ICS) board members on cancer services and help to ensure that local cancer strategies are delivered.
What role for pharma in helping to deliver integrated care?

Phil explained how Dorset ICS runs “a family budgeting system”, where money has already moved from one organisation to another to achieve balance across the system. ... To hear more from Dr Phil Richardson, of Dorset ICS, regarding integrated care
What does the new NHS plan mean for pharma?

decade. The document, which will provide the basis for local NHS organisations’ plans, states that, by April 2021, all areas of England will be covered by an Integrated Care System (ICS), ... with typically one Clinical Commissioning Group (CCG) per
How can pharma engage with key stakeholders on NHS service transformation?

It should also be noted that in the 14 areas, which are early movers from STP to ICS/ICPPs (Integrated Care Provider Partnerships), former low-mid ranking CCG commissioners and project
How can pharma engage with key decision-makers in new, collaborative NHS care models?

This has resulted in an increasingly complex, multi-layered healthcare system that is seeing some GPs taking on wide-ranging responsibilities in Integrated Care System (ICS) areas. . ... work in an alliance within the ICS.

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Account Director, Medical Education: Salary TBC

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Senior Medical Writer: Salary TBC

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Subscribe to our email news alerts

PMHub

Add my company

Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

The 2019 CPhI Pharma Index Report: Examining this year’s industry performance...
Five key trends in precision and personalised healthcare: Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications: Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...